桥本甲状腺炎合并甲状腺乳头状癌的临床及病理学特征

doi:10.6040/j.issn.1671-7554.0.2016.333

摘要/Abstract

摘要： 目的分析桥本甲状腺炎(HT)合并甲状腺乳头状癌(PTC)的临床及病理学特征。方法 2013年10月至2015年10月共收治PTC患者297例。其中PTC合并HT者49例为研究组,男5例,女44例, 24~67岁,<45岁者27例。单纯PTC者248例为对照组,其中男60例,女188例,17~76岁,<45岁者97例。分析两组患者的临床资料,包括性别、年龄、甲状腺弥漫性肿大、血清自身免疫抗体水平、是否存在包膜侵犯、肿瘤大小、术中冰冻病理准确率、中央区淋巴结转移、TNM分期,并行统计学分析。结果与对照组比较,研究组在性别、年龄、甲状腺弥漫性肿大、血清自身免疫抗体水平、中央区淋巴结转移方面差异均有统计学意义(P均<0.05),而是否存在包膜侵犯、肿瘤大小、术中快速病理、TNM分期差异无统计学意义(P>0.05)。结论 HT合并PTC多见于女性,发病年龄较早,可伴有甲状腺弥漫性肿大及血清自身免疫抗体的升高,早期即可出现淋巴结转移。提示对HT患者应定期复查,以利其早期病变的诊疗。

关键词: 桥本甲状腺炎, 病理学特征, 甲状腺乳头状癌

Abstract: Objective To analyze the clinicopathologic features of Hashimotos thyroiditis(HT)complicated with papillary thyroid cancer(PTC). Methods A total of 297 patients with PTC treated surgically during Oct. 2013 and Oct. 2015 were divided into 2 groups: experimental group(PTC complicated with HT, n=49, 5 males and 44 females, aged 24-67 years, 27 cases < 45 years), and control group(PTC only, n=248, 60 males and 188 females, aged 17-76 years, 97 cases < 45 years). The clinical data of the 2 groups were compared and analyzed statistically, including gender, age, diffusely enlarged thyroid gland, level of serum autoimmune antibody, capsular invasion, tumor size, intraoperative frozen pathology, and TNM staging. Results There were statistically significant differences between the 2 groups in gender, age, diffusely enlarged thyroid gland, level of serum autoimmune antibody and central lymph node metastasis(all P<0.05), but no statistical differences in capsular invasion, tumor size, intraoperative frozen pathology and TNM staging(all P>0.05). Conclusion HT complicated with PTC is more common in female patients, especially young women. It usually manifests as diffusely enlarged thyroid, increased serum autoimmune antibody and early lymph node metastasis. HT patients should check regularly for timely diagnosis and treatment.

Key words: Hashimotos thyroiditis, Papillary thyroid cancer, Pathologic features

中图分类号:

R736.1

郝战宇,李波. 桥本甲状腺炎合并甲状腺乳头状癌的临床及病理学特征[J]. 山东大学学报（医学版）, 2016, 54(6): 73-77.

HAO Zhanyu, LI Bo. Clinicopathologic features of Hashimotos thyroiditis complicated with papillary thyroid cancer[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(6): 73-77.

参考文献

[1] 滕志兰, 巩维进, 张树青, 等. 聚乙二醇干扰素α-2a联合利巴韦林治疗慢性丙型肝炎合并慢性淋巴细胞性甲状腺炎的临床观察[J]. 中华肝脏病杂志, 2013, 21(2): 101-104. TENG Zhilan, GONG Weijin, ZHANG Shuqing, et al. Clinical observation of Hashimoto thyroiditis in patients with chronic hepatitis C undergoing pegylated-interferon alpha-2a and ribavirin combination therapy[J]. Chinese Journal of Hepatology Chin J Hepatol, 2013, 21(2): 101-104.
[2] 陈佳瑞, 王家东. 桥本甲状腺炎与甲状腺乳头状癌相关性的研究进展[J]. 现代肿瘤医学, 2009, 17(12): 2449-2451. CHEN Jiarui, WANG Jiadong. Research progress of Hashimotos thyroiditis with papillary thyroid carcinoma[J]. Journal of Modern Oncology, 2009, 17(12): 2449-2451.
[3] Zhang L, Li H, Ji QH, et al. The clinical features of papillary thyroid cancer in Hashimotos thyroiditis patients from an area with a high prevalence of Hashimotos disease[J]. BMC Cancer, 2012, 12(1): 610. doi: 10.1186/1471-2407-12-610.
[4] Lun Y, Wu X, Xia Q, et al. Hashimotos thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis[J]. Otolaryngol Head Neck Surg, 2013,148(3): 396-402.
[5] 邵自功, 易德会, 钟鑫平, 等. 慢性淋巴细胞性甲状腺炎合并甲状腺癌104例临床分析[J].中国医科大学学报, 2011, 40(12): 1137-1139. SHAO Zigong, YI Dehui, ZHONG Xinping, et al. Clinical analysis of chronic lymphocytic thyroiditis coexisting with thyroid cancer in 104 patients[J]. Journal of China Medical University, 2011, 40(12): 1137-1139.
[6] 林琳,郑向前,刘磊,等.多灶性甲状腺乳头状癌的生物学特性及治疗分析[J].中华普通外科杂志,2010,25(8):621-623. LIN Lin, ZHENG Xiangqian, LIU Lei, et al. Multifocal papillary thyroid carcinoma[J]. Chinese Journal of General Surgery, 2010, 25(8): 621-623.
[7] 于亚静, 杨彩哲, 关小宏, 等. 甲状腺癌与桥本甲状腺炎及其他相关危险因素的研究[J].国际内分泌代谢杂志, 2015, 35(1): 27-30. YU Yajing, YANG Caizhe, GUAN Xiaohong, et al. Relationship between thyroid carcinoma, Hashimotos thyroiditis and other related risk factors[J]. International Journal of Endocrinology and Metabolism, 2015, 35(1): 27-30.
[8] Ahn D, Heo SJ, Park JH, et al. Clinical relationship between Hashimotos thyroiditis and papillary throid cancer[J]. Acta Oncol, 2011, 50(8): 1228-1234.
[9] 张顺霞, 姜责, 李淑霞, 等. 桥本甲状腺炎合并乳头状甲状腺癌的临床分析[J]. 宁夏医科大学学报, 2015, 37(10): 1205-1207. ZHANG Shunxia, JIANG Ze, LI Shuxia, et al. Clinical analysis of Hashimotos thyroiditis with papillary thyroid cancer[J]. Journal of Ningxia Medical University, 2015, 37(10): 1205-1207.
[10] 伦语, 吴小雨, 辛世杰, 等. 桥本甲状腺炎与甲状腺乳头状癌关系的临床研究[J]. 中国普通外科杂志, 2014, 23(5): 584-590. LUN Yu, WU Xiaoyu, XIN Shijie, et al. Relationship between Hashimotos thyroiditis and papillary thyroid cancer: a clinical analysis[J]. Chinese Journal of General Surgery, 2014, 23(5): 584-590.
[11] 郑荆州, 童传明, 吴高松. 微小甲状腺癌合并桥本氏甲状腺炎的临床病理及颈淋巴结转移特征[J]. 中国普通外科杂志, 2014, 23(11): 1557-1560. ZHENG Jingzhou, TONG Chuanming, WU Gaosong. Clinicopathologic and cervical lymph node metastatic features in patients with papillary thyroid microcarcinoma and concomitant Hashimotos thyroiditis[J]. Chinese Journal of General Surgery, 2014, 23(11): 1557-1560.
[12] Yoon YH, Kim HJ, Lee JW, et al. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis[J]. Eur Arch Otorhinolaryngol, 2012, 269(3): 1013-1017.
[13] 李玺, 郭卫平, 邱万寿, 等. 桥本甲状腺炎合并甲状腺癌的临床特点[J/CD]. 中华普通外科学文献, 2010, 5(5): 402-405. LI Xi, GUO Weiping, QIU Wanshou, et al. Clinical features of Hashimotos thyroiditis complicated with thyroid carcinoma[J/CD]. Chinese Archives of General Surgery, 2010, 5(5): 402-405.
[14] 杨践, 何永刚, 蔡伟耀, 等. 桥本甲状腺炎合并甲状腺癌的临床病理研究[J]. 诊断学理论与实践, 2005, 4(1): 12-16. YANG Jian, HE Yonggang, CAI Weiyao, et al. A clinicopathological study on the Hashimotos thyroiditis in combination with papillary thyroid carcinoma[J]. Journal of Diagnostics Concepts & Practice, 2005, 4(1): 12-16.
[15] 朱有志, 陈祥锦, 张真真, 等. 甲状腺癌并存桥本甲状腺炎的临床和病理分析[J]. 中国肿瘤临床, 2012, 39(4): 217-220. ZHU Youzhi, CHEN Xiangjin, ZHANG Zhenzhen, et al. Clinical and pathological analysis of thyroid carcinoma coexistent with hashimotos thyroiditis[J]. Chinese Journal of Clinical Oncology, 2012, 39(4): 217-220.
[16] 唐彩华, 贾晓娟, 许泽清. 73例分化型甲状腺癌术后¹³¹I治疗随访结果分析[J]. 肿瘤学杂志, 2014, 20(1): 72-74. TANG Caihua, JIA Xiaojuan, XU Zeqing. An analysis of the follow-up results with ¹³¹I radiotherapy in 73 cases with well differentiated thyroid cancer postoperation[J]. Journal of Chinese Oncology, 2014, 20(1): 72-74.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed